Activated marrow-infiltrating lymphocytes effectively target plasma cells and their clonogenic precursors

Kimberly NOONAN; William MATSUI; Paolo SERAFINI; Rebecca CARBLEY; Gladys TAN; Jahan KHALILI; Mark BONYHADI; Hyam LEVITSKY; Katie WHARTENBY; Ivan BORRELLO

doi:10.1158/0008-5472.CAN-04-3337

Back

Activated marrow-infiltrating lymphocytes effectively target plasma cells and their clonogenic precursors

Journal article

Open access

Peer reviewed

Activated marrow-infiltrating lymphocytes effectively target plasma cells and their clonogenic precursors

Kimberly NOONAN, William MATSUI, Paolo SERAFINI, Rebecca CARBLEY, Gladys TAN, Jahan KHALILI, Mark BONYHADI, Hyam LEVITSKY, Katie WHARTENBY and Ivan BORRELLO

Cancer research (Chicago, Ill.), Vol.65(5), pp.2026-2034

2005

DOI: https://doi.org/10.1158/0008-5472.CAN-04-3337

PMID: 15753403

Abstract

Biological and medical sciences

Medical sciences

Antineoplastic agents

Pharmacology. Drug treatments

Files and links (1)

url

https://doi.org/10.1158/0008-5472.CAN-04-3337View

Published (Version of record) Open

Metrics

29 Record Views

99 Times Cited - Web of Science

See more details

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Citation topics: 1 Clinical & Life Sciences; 1.6 Immunology; 1.6.358 Dendritic Cells
Web Of Science research areas: Oncology
ESI research areas: Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

Source: InCites

Details

Title: Activated marrow-infiltrating lymphocytes effectively target plasma cells and their clonogenic precursors
Creators: Kimberly NOONAN - Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Johns Hopkins University, Baltimore, Maryland, United States
William MATSUI - Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Johns Hopkins University, Baltimore, Maryland, United States
Paolo SERAFINI - Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Johns Hopkins University, Baltimore, Maryland, United States
Rebecca CARBLEY - Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Johns Hopkins University, Baltimore, Maryland, United States
Gladys TAN - Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Johns Hopkins University, Baltimore, Maryland, United States
Jahan KHALILI - Xcyte Therapies, Seattle, Washington, United States
Mark BONYHADI - Xcyte Therapies, Seattle, Washington, United States
Hyam LEVITSKY - Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Johns Hopkins University, Baltimore, Maryland, United States
Katie WHARTENBY - Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Johns Hopkins University, Baltimore, Maryland, United States
Ivan BORRELLO - Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Johns Hopkins University, Baltimore, Maryland, United States
Publication Details: Cancer research (Chicago, Ill.), Vol.65(5), pp.2026-2034
Publisher: American Association for Cancer Research; Philadelphia, PA
Academic Unit: Miller School of Medicine; Microbiology and Immunology Research
Language: English
Resource Type: Journal article
PMID: 15753403
Record Identifier: 991031561216602976